Evidence map›Paper›PMID 39983942›Full record

ArticleAmerican journal of ophthalmology2025

Detection of Ocular Surface Squamous Neoplasia Using Artificial Intelligence With Anterior Segment Optical Coherence Tomography.

Jason A Greenfield, Rafael Scherer, Diego Alba, Sofia De Arrigunaga, Osmel Alvarez, Sotiria Palioura, Afshan Nanji, Ghada Al Bayyat, Douglas Rodrigues da Costa, William Herskowitz and 9 more

Abstract read
In one paragraph

Article in American journal of ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. A Review of the Use of Artificial Intelligence in Ophthalmology Imaging: Approximation to Ocular Histopathology.APMIS : acta pathologica, microbiologica, et immunologica Scandinavica · 2026
    Review
  2. Review
  3. Review
  4. Utilizing artificial intelligence for the diagnosis of ocular surface squamous neoplasia with ultrasound biomicroscopy images.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Article
  5. Review
  6. Enhanced Imaging of Ocular Surface Lesions.Journal of clinical medicine · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Jason A GreenfieldFrom the Bascom Palmer Eye Institute (J.A.G., R.S., D.A., S.D.A., O.A., S.P., D.R.C., W.H., M.A., A.J., H.A.K., W.W., M.A.S., R.O., A.G., F.A.M., C.L.K.), University of Miami Miller School of Medicine, Miami, Florida, USA.
Rafael SchererFrom the Bascom Palmer Eye Institute (J.A.G., R.S., D.A., S.D.A., O.A., S.P., D.R.C., W.H., M.A., A.J., H.A.K., W.W., M.A.S., R.O., A.G., F.A.M., C.L.K.), University of Miami Miller School of Medicine, Miami, Florida, USA.
Diego AlbaFrom the Bascom Palmer Eye Institute (J.A.G., R.S., D.A., S.D.A., O.A., S.P., D.R.C., W.H., M.A., A.J., H.A.K., W.W., M.A.S., R.O., A.G., F.A.M., C.L.K.), University of Miami Miller School of Medicine, Miami, Florida, USA.
Sofia De ArrigunagaFrom the Bascom Palmer Eye Institute (J.A.G., R.S., D.A., S.D.A., O.A., S.P., D.R.C., W.H., M.A., A.J., H.A.K., W.W., M.A.S., R.O., A.G., F.A.M., C.L.K.), University of Miami Miller School of Medicine, Miami, Florida, USA.
Osmel AlvarezFrom the Bascom Palmer Eye Institute (J.A.G., R.S., D.A., S.D.A., O.A., S.P., D.R.C., W.H., M.A., A.J., H.A.K., W.W., M.A.S., R.O., A.G., F.A.M., C.L.K.), University of Miami Miller School of Medicine, Miami, Florida, USA.
Sotiria PaliouraFrom the Bascom Palmer Eye Institute (J.A.G., R.S., D.A., S.D.A., O.A., S.P., D.R.C., W.H., M.A., A.J., H.A.K., W.W., M.A.S., R.O., A.G., F.A.M., C.L.K.), University of Miami Miller School of Medicine, Miami, Florida, USA.
Afshan NanjiOregon Health & Science University (A.N.), Portland, Oregon, USA.
Ghada Al BayyatGovernment Hospitals (G.A.B.), Manama, Kingdom of Bahrain.
Douglas Rodrigues da CostaFrom the Bascom Palmer Eye Institute (J.A.G., R.S., D.A., S.D.A., O.A., S.P., D.R.C., W.H., M.A., A.J., H.A.K., W.W., M.A.S., R.O., A.G., F.A.M., C.L.K.), University of Miami Miller School of Medicine, Miami, Florida, USA.
William HerskowitzFrom the Bascom Palmer Eye Institute (J.A.G., R.S., D.A., S.D.A., O.A., S.P., D.R.C., W.H., M.A., A.J., H.A.K., W.W., M.A.S., R.O., A.G., F.A.M., C.L.K.), University of Miami Miller School of Medicine, Miami, Florida, USA.
Michael AntoniettiFrom the Bascom Palmer Eye Institute (J.A.G., R.S., D.A., S.D.A., O.A., S.P., D.R.C., W.H., M.A., A.J., H.A.K., W.W., M.A.S., R.O., A.G., F.A.M., C.L.K.), University of Miami Miller School of Medicine, Miami, Florida, USA.
Alessandro JammalFrom the Bascom Palmer Eye Institute (J.A.G., R.S., D.A., S.D.A., O.A., S.P., D.R.C., W.H., M.A., A.J., H.A.K., W.W., M.A.S., R.O., A.G., F.A.M., C.L.K.), University of Miami Miller School of Medicine, Miami, Florida, USA.
Hasenin Al-KhersanFrom the Bascom Palmer Eye Institute (J.A.G., R.S., D.A., S.D.A., O.A., S.P., D.R.C., W.H., M.A., A.J., H.A.K., W.W., M.A.S., R.O., A.G., F.A.M., C.L.K.), University of Miami Miller School of Medicine, Miami, Florida, USA.
Winfred WuFrom the Bascom Palmer Eye Institute (J.A.G., R.S., D.A., S.D.A., O.A., S.P., D.R.C., W.H., M.A., A.J., H.A.K., W.W., M.A.S., R.O., A.G., F.A.M., C.L.K.), University of Miami Miller School of Medicine, Miami, Florida, USA.
Mohamed Abou ShoushaFrom the Bascom Palmer Eye Institute (J.A.G., R.S., D.A., S.D.A., O.A., S.P., D.R.C., W.H., M.A., A.J., H.A.K., W.W., M.A.S., R.O., A.G., F.A.M., C.L.K.), University of Miami Miller School of Medicine, Miami, Florida, USA.
Robert O'BrienFrom the Bascom Palmer Eye Institute (J.A.G., R.S., D.A., S.D.A., O.A., S.P., D.R.C., W.H., M.A., A.J., H.A.K., W.W., M.A.S., R.O., A.G., F.A.M., C.L.K.), University of Miami Miller School of Medicine, Miami, Florida, USA.
Anat GalorFrom the Bascom Palmer Eye Institute (J.A.G., R.S., D.A., S.D.A., O.A., S.P., D.R.C., W.H., M.A., A.J., H.A.K., W.W., M.A.S., R.O., A.G., F.A.M., C.L.K.), University of Miami Miller School of Medicine, Miami, Florida, USA; Department of Ophthalmology (A.G.), Miami Veterans Administration Medical Center, Miami, Florida, USA.
Felipe A MedeirosFrom the Bascom Palmer Eye Institute (J.A.G., R.S., D.A., S.D.A., O.A., S.P., D.R.C., W.H., M.A., A.J., H.A.K., W.W., M.A.S., R.O., A.G., F.A.M., C.L.K.), University of Miami Miller School of Medicine, Miami, Florida, USA.
Carol L KarpFrom the Bascom Palmer Eye Institute (J.A.G., R.S., D.A., S.D.A., O.A., S.P., D.R.C., W.H., M.A., A.J., H.A.K., W.W., M.A.S., R.O., A.G., F.A.M., C.L.K.), University of Miami Miller School of Medicine, Miami, Florida, USA. Electronic address: ckarp@med.miami.edu.

Funding

Miami Clinical and Translational Science InstituteUM1TR004556 · NCATS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Olveen Carrasquillo, ERIN N KOBETZ · 2023 to 2026
$16.0M
Shared Equipment ModuleP30EY014801 · NEI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Victor L Perez · 2004 to 2026
$12.2M
The BCI (Brain Computer Interface) Glaucoma Study: Objective Home-Based Detection of Progressive Visual Function Loss in GlaucomaR01EY029885 · NEI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI MEDEIROS, FELIPE · 2019 to 2022
$2.2M
Tear protein biomarkers of refractive surgery painR61EY032468 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI AICHER, SUE A, GALOR, ANAT · 2020 to 2022
$2.0M
Dry Eye and MicroenvironmentR01EY026174 · NEI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI GALOR, ANAT, KUMAR, NARESH · 2016 to 2020
$1.9M
BLRD VA I01 BX004893CSRD VA I01 CX002015NCATS NIH HHS UM1 TR004556NEI NIH HHS P30 EY014801NEI NIH HHS R01 EY026174NEI NIH HHS R01 EY029885NEI NIH HHS R61 EY032468
6 · The paper itself

Abstract

purposeTo develop and validate a deep learning (DL) model to differentiate ocular surface squamous neoplasia (OSSN) from pterygium and pinguecula using high-resolution anterior segment optical coherence tomography (AS-OCT).

designRetrospective Diagnostic Accuracy Study.

methodsSetting: Single-center. STUDY POPULATION: All eyes with a clinical or biopsy-proven diagnosis of OSSN, pterygium, or pinguecula that received AS-OCT imaging. PROCEDURES: Imaging data was extracted from Optovue AS-OCT (Fremont, CA) and patients' clinical or biopsy-proven diagnoses were collected from electronic medical records. A DL classification model was developed using two methodologies: (1) a masked autoencoder was trained with unlabeled data from 105,859 AS-OCT images of 5746 eyes and (2) a Vision Transformer supervised model coupled to the autoencoder used labeled data for fine-tuning a binary classifier (OSSN vs non-OSSN lesions). A sample of 2022 AS-OCT images from 523 eyes (427 patients) were classified by expert graders into "OSSN or suspicious for OSSN" and "pterygium or pinguecula." The algorithm's diagnostic performance was evaluated in a separate test sample using 566 scans (62 eyes, 48 patients) with biopsy-proven OSSN and compared with expert clinicians who were masked to the diagnosis. Analysis was conducted at the scan-level for both the DL model and expert clinicians, who were not provided with clinical images or supporting clinical data. MAIN OUTCOME: Diagnostic performance of expert clinicians and the DL model in identifying OSSN on AS-OCT scans.

resultsThe DL model had an accuracy of 90.3% (95% confidence intervals [CI]: 87.5%-92.6%), with sensitivity of 86.4% (95% CI: 81.4%-90.4%) and specificity of 93.2% (95% CI: 89.9%-95.7%) compared to the biopsy-proven diagnosis. Expert graders had a lower sensitivity 69.8% (95% CI: 63.6%-75.5%) and slightly higher specificity 98.5% (95% CI: 96.4%-99.5%) than the DL model. The area under the receiver operating characteristic curve for the DL model was 0.945 (95% CI: 0.918-0.972) and significantly greater than expert graders (area under the receiver operating characteristic curve = 0.688, P < .001).

conclusionsA DL model applied to AS-OCT scans demonstrated high accuracy, sensitivity, and specificity in differentiating OSSN from pterygium and pinguecula. Interestingly, the model had comparable diagnostic performance to expert clinicians in this study and shows promise for enhancing clinical decision-making. Further research is warranted to explore the integration of this artificial intelligence-driven approach in routine screening and diagnostic protocols for OSSN.

Indexed as

Anterior Eye SegmentArtificial IntelligenceCarcinoma, Squamous CellConjunctival NeoplasmsCorneal DiseasesDeep LearningPterygiumTomography, Optical CoherenceAdultAgedAged, 80 and overDiagnosis, DifferentialFemaleHumansMaleMiddle Aged

Identifiers

PMID39983942
PMCPMC11985264

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.